News

2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
11/6/2024
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
10/30/2024
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
New studies test immunotherapy to boost breast cancer treatment and prevent return
10/30/2024
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Attend a free virtual symposium on melanoma, Oct. 25
10/8/2024
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
Prostate cancer study includes a tumor test to personalize treatment
9/27/2024
A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.
Stay healthy and on your feet with free fall prevention events
9/19/2024
Free educational presentations from Providence Senior Health are taking place in September in Beaverton, Hillsboro, Seaside and Medford. See the schedule and registration information.
Meet physician scientist, Dr. Allie Grossmann
9/23/2024
Dr. Allie Grossmann’s new lab at Earle A. Chiles Research Institute is focused on understanding how tumors communicate with their environment, grow, survive and spread.
‘Exploring the end of life creates opportunities to celebrate life’
9/17/2024
Hospice volunteers offer respite to family members, care for patients at the end of their lives and help people navigate grief. Learn about their service and how to volunteer.
Dr. Walter Urba announces retirement from Providence
8/22/2024
Dr. Walter Urba, a pioneer and key figure in the development of immunotherapy, will retire from Providence Cancer Institute at the end of year.
Dr. Bernard Fox honored for his lifetime contributions to cancer research
8/23/2024
Prominent cancer scientist Dr. Bernard Fox recognized for his work to advance the field of cancer immunotherapy through increasing public understanding, awareness and research efforts.
Can these new studies offer hope for people with lung and head and neck cancers?
8/27/2024
A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.
Cancer survivor speaks with doctor he credits for saving his life
8/27/2024
Cancer survivor Mark Williams chats with Dr. Brendan Curti about